BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hulin A, Stocco J, Bouattour M. Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma. Clin Pharmacokinet 2019;58:983-1014. [PMID: 31093928 DOI: 10.1007/s40262-019-00740-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zarisfi M, Kasaeian A, Wen A, Liapi E. Systematic Review and Pharmacokinetic Meta-analysis of Doxorubicin Exposure in Transcatheter Arterial Chemoembolization and Doxorubicin-Eluted Beads Chemoembolization for Treatment of Unresectable Hepatocellular Carcinoma. Eur J Drug Metab Pharmacokinet 2022. [PMID: 35543895 DOI: 10.1007/s13318-022-00762-z] [Reference Citation Analysis]
2 Ju S, Wang W, Chen P, Li F, Li H, Wang M, Han X, Ren J, Duan X. Drug-eluting bead transarterial chemoembolization followed by apatinib is effective and safe in treating hepatocellular carcinoma patients with BCLC stage C. Clin Res Hepatol Gastroenterol 2022;:101859. [PMID: 34999249 DOI: 10.1016/j.clinre.2022.101859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qin Y, Wang S, Wen Q, Xia Q, Wang S, Chen G, Sun J, Shen C, Song S. Interactions Between Ephedra sinica and Prunus armeniaca: From Stereoselectivity to Deamination as a Metabolic Detoxification Mechanism of Amygdalin. Front Pharmacol 2021;12:744624. [PMID: 34899298 DOI: 10.3389/fphar.2021.744624] [Reference Citation Analysis]
4 Cha Y, Wei Z, Ma C, Zhang L, Ramirez G. Intelligent Algorithm-Based Computed Tomography Image Features in Diagnosis of the Effect of Radiofrequency Ablation in Liver Cancer. Scientific Programming 2021;2021:1-9. [DOI: 10.1155/2021/3422484] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fazary AE, Alfaifi MY, Elbehairi SEI, Amer ME, Nasr MSM, Abuamara TMM, Badr DA, Ju YH, Mohamed AF. Bioactivity Studies of Hesperidin and XAV939. ACS Omega 2021;6:20042-52. [PMID: 34368589 DOI: 10.1021/acsomega.1c03080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ye Z, Wu L, Zhang X, Hu Y, Zheng L. Quantification of sorafenib, lenvatinib, and apatinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS. J Pharm Biomed Anal 2021;202:114161. [PMID: 34052550 DOI: 10.1016/j.jpba.2021.114161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Shou L, Shao T, Zhao F, Chen S, Chen Q, Shu Q. The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand-Foot Skin Reaction. Cancer Manag Res 2021;13:45-53. [PMID: 33442293 DOI: 10.2147/CMAR.S285002] [Reference Citation Analysis]
8 Wang D, Yang X, Lin J, Bai Y, Long J, Yang X, Seery S, Zhao H. Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials. Therap Adv Gastroenterol 2020;13:1756284820932483. [PMID: 32636928 DOI: 10.1177/1756284820932483] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Shuwen H, Xi Y, Quan Q, Yin J, Miao D. Can small nucleolar RNA be a novel molecular target for hepatocellular carcinoma? Gene 2020;733:144384. [PMID: 31978508 DOI: 10.1016/j.gene.2020.144384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Yu B, Ni D, Rosenkrans ZT, Barnhart TE, Wei H, Ferreira CA, Lan X, Engle JW, He Q, Yu F, Cai W. A "Missile-Detonation" Strategy to Precisely Supply and Efficiently Amplify Cerenkov Radiation Energy for Cancer Theranostics. Adv Mater 2019;31:e1904894. [PMID: 31709622 DOI: 10.1002/adma.201904894] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Ai L, Xu Z, Yang B, He Q, Luo P. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management. Expert Rev Clin Pharmacol 2019;12:1121-7. [PMID: 31679411 DOI: 10.1080/17512433.2019.1689122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Zhao H, Zhu P, Han T, Ye Q, Xu C, Wu L, Liu F, Yin W, Li Z, Guo Y. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease. J Clin Lab Anal 2020;34:e23075. [PMID: 31659795 DOI: 10.1002/jcla.23075] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Zhang X, Lin X, Qiu H, Peng Z. An investigation of efficacy, safety, and prognostic factors of drug-eluting beads-transarterial chemoembolization operation with CalliSpheres® Microspheres in treating Chinese hepatocellular carcinoma patients. J Clin Lab Anal 2019;33:e22975. [PMID: 31328832 DOI: 10.1002/jcla.22975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]